Defining Low Disease Activity States in Psoriatic Arthritis Using Novel Composite Disease Instruments

REFERENCES

1. 1.↵
   1. Coates LC,
   2. Helliwell PS

   . Defining low disease activity states in psoriatic arthritis using novel composite disease instruments. J Rheumatol 2016;43:371–5.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Coates LC,
   2. Fransen J,
   3. Helliwell PS

   . Defining disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 2010;69:48–53.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Helliwell PS,
   2. FitzGerald O,
   3. Fransen J

   . Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response. J Rheumatol 2014;41:1212–7.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Helliwell PS,
   2. FitzGerald O,
   3. Fransen J,
   4. Gladman DD,
   5. Kreuger GG,
   6. Callis-Duffin K,
   7. et al.

   The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis 2013;72:986–91.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Perrotta FM,
   2. Marchesoni A,
   3. Lubrano E

   . Minimal disease activity and remission in psoriatic arthritis patients treated with anti-TNF-α drugs. J Rheumatol 2016;43:350–5.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Husic R,
   2. Gretler J,
   3. Felber A,
   4. Graninger WB,
   5. Duftner C,
   6. Hermann J,
   7. et al.

   Disparity between ultrasound and clinical findings in psoriatic arthritis. Ann Rheum Dis 2014;73:1529–36.

   OpenUrlAbstract/FREE Full Text